Literature DB >> 28864306

A meta-analysis of nevus-associated melanoma: Prevalence and practical implications.

Riccardo Pampena1, Athanassios Kyrgidis1, Aimilios Lallas2, Elvira Moscarella1, Giuseppe Argenziano3, Caterina Longo4.   

Abstract

The reported prevalence of nevus-associated melanoma varies substantially. We performed a systematic review and meta-analysis to determine the incidence and prevalence of this disease; we also performed subanalyses considering age, tumor thickness, and nevus-type classification. In 38 observational cohort and case-control studies, 29.1% of melanomas likely arose from a preexisting nevus and 70.9% de novo. Any given melanoma was 64% less likely to be nevus-associated than de novo (risk ratio 0.36, 95% confidence interval [CI] 0.29-0.44; P < .001; I2 = 99%); nevus-associated melanomas had a lower mean Breslow thickness than de novo melanomas (mean difference -0.39 mm; 95% CI -0.60 to -0.18; P = .0003; I2 = 66%). No significant differences were noted regarding the association of nevus-associated melanomas with nondysplastic nevi or dysplastic nevi (risk ratio 0.77, 95% CI 0.49-1.20; P = .24; I2 = 98%).
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dysplastic nevus; melanoma; meta-analysis; nevus-associated; prevalence; thickness

Mesh:

Year:  2017        PMID: 28864306     DOI: 10.1016/j.jaad.2017.06.149

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  Is There More Than One Road to Nevus-Associated Melanoma?

Authors:  Roberta Vezzoni; Claudio Conforti; Silvia Vichi; Roberta Giuffrida; Chiara Retrosi; Giovanni Magaton-Rizzi; Nicola Di Meo; Maria Antonietta Pizzichetta; Iris Zalaudek
Journal:  Dermatol Pract Concept       Date:  2020-04-03

2.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

3.  Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.

Authors:  Bernice Y Yan; Sandra Garcet; Nicholas Gulati; Felix Kiecker; Judilyn Fuentes-Duculan; Patricia Gilleaudeau; Mary Sullivan-Whalen; Avner Shemer; Hiroshi Mitsui; James G Krueger
Journal:  Exp Dermatol       Date:  2018-12-21       Impact factor: 3.960

4.  Characterizing melanoma in the setting of oculocutaneous albinism: an analysis of the literature.

Authors:  S Ravichandran; P Funchain; J Arbesman
Journal:  Arch Dermatol Res       Date:  2022-07-18       Impact factor: 3.033

Review 5.  Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review.

Authors:  Dilki Jayasinghe; Kaitlin L Nufer; Brigid Betz-Stablein; H Peter Soyer; Monika Janda
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-30

6.  Inactivation of the Hippo tumor suppressor pathway promotes melanoma.

Authors:  Marc A Vittoria; Nathan Kingston; Kristyna Kotynkova; Eric Xia; Rui Hong; Lee Huang; Shayna McDonald; Andrew Tilston-Lunel; Revati Darp; Joshua D Campbell; Deborah Lang; Xiaowei Xu; Craig J Ceol; Xaralabos Varelas; Neil J Ganem
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

7.  The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.

Authors:  Ajit J Nirmal; Zoltan Maliga; Tuulia Vallius; Sandro Santagata; Peter K Sorger; Brian Quattrochi; Alyce A Chen; Connor A Jacobson; Roxanne J Pelletier; Clarence Yapp; Raquel Arias-Camison; Yu-An Chen; Christine G Lian; George F Murphy
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

8.  Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort Study.

Authors:  Xavier Bosch-Amate; Sebastian Podlipnik; Constanza Riquelme-Mc Loughlin; Cristina Carrera; Alicia Barreiro-Capurro; Adriana García-Herrera; Llucia Alós; Josep Malvehy; Susana Puig
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

Review 9.  The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice.

Authors:  Gerardo Ferrara; Giuseppe Argenziano
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

10.  Clinical-dermoscopic similarities between atypical nevi and early stage melanoma.

Authors:  Cristina-Raluca Jitian Mihulecea; Simona Frățilă; Maria Rotaru
Journal:  Exp Ther Med       Date:  2021-06-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.